Fenofibrates in the Treatment of Primary Biliary Cholangitis
New data suggest adding fibrate therapy to frontline PBC treatment could result in earlier and higher rates of biochemical response.
Read More
Ustekinumab Versus Adalimumab in Crohn's Disease: Reviewing the Phase 3B SEAVUE Trial
Analysis from a multicenter, randomized, double-blind, parallel group study comparing the drugs as induction and maintenance therapies in biologic-naïve patients.